Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07281118 · ClinicalTrials.gov registry record · NA

Intercostal Cryoanalgesia in Double Lung Transplant Recipients

A NA study of Post-operative Pain Management, sponsored by University of California, Los Angeles.

Recruiting
Registry status
NA
Development phase
148
Enrollment target
3
Study locations

NCT07281118 is a NA study of Post-operative Pain Management that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 148 participants. The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07281118, a NA study of Post-operative Pain Management, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
NA
Development phase
148 participants
Enrollment target
3
Study locations

Study Summary

This study is testing a new way to help manage pain after a double lung transplant. Instead of relying only on strong pain medicines like opioids, doctors will use a cold-therapy probe during surgery to help numb the nerves near the incision. Researchers want to see if this method can reduce the need for opioids and improve recovery.

Interventions

  • DEVICE Atricure CryoSPHERE MAX Probe

Study Locations (3)

California

  • University of California Los Angeles - Los Angeles
  • University of California San Francisco - San Francisco

Texas

  • Baylor University - Waco

Trial Details

FieldValue
Enrollment Target 148 participants
Start Date 2025-12-16
Est. Completion 2027-11-24
Phase NA

What the Registry Record Tells You About NCT07281118

The ClinicalTrials.gov registry entry for NCT07281118 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Post-operative Pain Management appearing as the primary indexed condition, and to 1 intervention - of which Atricure CryoSPHERE MAX Probe is the first listed.

NCT07281118 reports 3 study locations spanning 2 distinct geographic areas - top geographies include California, Texas.

Frequently Asked Questions

What is clinical trial NCT07281118 about?

NCT07281118 is a clinical study titled "Intercostal Cryoanalgesia in Double Lung Transplant Recipients". This study is testing a new way to help manage pain after a double lung transplant. Instead of relying only on strong pain medicines like opioids, doctors will use a cold-therapy probe during surgery to help numb the nerves near the incision. Researchers want to see if this method can reduce the nee...

What is the current status of trial NCT07281118?

This trial is currently recruiting. It is a NA study. The enrollment target is 148 participants. The study started on 2025-12-16. Estimated completion is 2027-11-24.

What conditions does trial NCT07281118 study?

This clinical trial studies the following conditions: Post-operative Pain Management.

What interventions are being tested in trial NCT07281118?

The interventions under investigation include: Atricure CryoSPHERE MAX Probe (DEVICE).

Who is sponsoring clinical trial NCT07281118?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07281118 being conducted?

This trial has 3 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post-operative Pain Management

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.